Prognostic implications of coronary physiological indices in patients with diabetes mellitus.

Coronary artery disease Coronary flow reserve Diabetes mellitus Enfermedad coronaria Fractional flow reserve Index of microcirculatory resistance Reserva de flujo coronario Reserva fraccional de flujo Índice de resistencia microcirculatoria

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 12 11 2019
accepted: 29 05 2020
pubmed: 19 7 2020
medline: 28 7 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

Has been performed of the prognostic value of coronary physiological indices in patients with diabetes mellitus (DM) after coronary revascularization deferral. We analyzed 714 patients (235 with DM) with deferred revascularization according to fractional flow reserve (> 0.80). A comprehensive physiological evaluation including coronary flow reserve (CFR), index of microcirculatory resistance, and fractional flow reserve was performed at the time of revascularization deferral. The median values of the CFR (2.88), fractional flow reserve (0.88), and index of microcirculatory resistance (17.85) were used to classify patients into high- or low-index groups. The primary outcome was the patient-oriented composite outcome (POCO) at 5 years, comprising all-cause death, any myocardial infarction, and any revascularization. Compared with the non-DM population, the DM population showed higher risk of POCO (HR, 2.49; 95%CI, 1.64-3.78; P<.001). In the DM population, the low-CFR group had a higher risk of POCO than the high-CFR group (HR, 3.22; 95%CI, 1.74-5.97; P <.001). In contrast, CFR values could not differentiate the risk of POCO in the non-DM population. There was a significant interaction between CFR and the presence of DM regarding the risk of POCO (P for interaction=.025). Independent predictors of POCO were a low CFR and family history of coronary artery disease in the DM population and percent diameter stenosis and multivessel disease in the non-DM population. The association between coronary physiological indices and clinical outcomes differs according to the presence of DM. In deferred patients, CFR is the most important prognostic factor in patients with DM, but not in those without DM.

Identifiants

pubmed: 32680779
pii: S1885-5857(20)30261-9
doi: 10.1016/j.rec.2020.06.007
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

682-690

Informations de copyright

Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Doyeon Hwang (D)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Jinlong Zhang (J)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Joo Myung Lee (JM)

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Joon-Hyung Doh (JH)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.

Chang-Wook Nam (CW)

Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.

Eun-Seok Shin (ES)

Division of Cardiology, Ulsan Hospital, Ulsan, South Korea and Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Tadashi Murai (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Hernán Mejía-Rentería (H)

Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.

Javier Escaned (J)

Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea; Institute of Aging, Seoul National University, Seoul, Korea. Electronic address: bkkoo@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH